Back to ONC

BeOne Medicines Ltd. Financing Cash Flow 2014-2026 | ONC

Beta

What is financing cash flow?

Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.

What is BeOne Medicines Ltd.'s current financing cash flow?

BeOne Medicines Ltd. (ONC) annual financing cash flow for 2025 was $1.06B, a 447.66% increase from 2024. BeOne Medicines Ltd. financing cash flow for the quarter ending March 31, 2026 was $68.6M.

What was BeOne Medicines Ltd.'s financing cash flow in 2024?

BeOne Medicines Ltd. annual financing cash flow for 2024 was $193.4M, a 53.55% decline from 2023.

What was BeOne Medicines Ltd.'s financing cash flow in 2023?

BeOne Medicines Ltd. annual financing cash flow for 2023 was $416.5M, a 2295.34% increase from 2022.

What is BeOne Medicines Ltd.'s 5-year financing cash flow CAGR?

BeOne Medicines Ltd. financing cash flow grew at a compound annual growth rate (CAGR) of 27.26% from FY2020 to FY2025, going from $5.20B to $1.06B over 5 years.

Financing Cash Flow History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR-27.3%
FY2020
$5.20B
→
FY2025
$1.06B
141516171819202122232425
5 years selected
Financing Cash Flow History
PeriodValueChangeSource
FY2025$1.06B+447.7%10-K
FY2024$193.4M-53.6%10-K
FY2023$416.5M+2295.3%10-K
FY2022$-19.0M-100.5%10-K
FY2021$3.64B-30.1%10-K
FY2020$5.20B+5972.4%10-K
FY2019$85.7M-94.9%10-K
FY2018$1.69B+244.8%10-K
FY2017$490.4M+28.7%10-K
FY2016$380.9M+269.1%10-K
FY2015$103.2M+97.8%10-K
FY2014$52.2M-10-K
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →